Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
December 23, 2020
Novocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference
December 14, 2020
Novocure Announces National Reimbursement in Switzerland for Optune® in Combination With Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
December 10, 2020
First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma
November 25, 2020
Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference
November 19, 2020
Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
November 11, 2020
Novocure Receives CE Mark for NovoTTF-100L™ System
November 10, 2020
Novocure Announces Agenda for Virtual Research and Development Day
November 9, 2020
Novocure Announces Closing of $150 Million Revolving Credit Facility with a Syndicate of Relationship Banks
November 5, 2020
Novocure Announces Closing of $575 Million 0% Convertible Senior Notes Private Placement
November 2, 2020
Novocure Prices $500 Million 0% Convertible Senior Notes Private Placement
November 2, 2020
Novocure Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
October 29, 2020
Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research
October 29, 2020
Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update
October 2, 2020
Novocure to Report Third Quarter 2020 Financial Results
September 29, 2020
Novocure to Host Virtual Research & Development Day
September 25, 2020
Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community
September 4, 2020
Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
August 13, 2020
Novocure Announces Expansion of Its Executive Leadership Team
July 30, 2020
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
July 28, 2020
Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
July 22, 2020
First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays
July 15, 2020
Novocure Announces Clinical Trial Collaboration with MSD to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer
July 8, 2020
Novocure Announces Over 100 Physicians in the U.S. Now Certified to Prescribe Optune Lua™
July 7, 2020
Novocure Enrolls Last Patient in HEPANOVA Trial Testing Tumor Treating Fields in Combination with Sorafenib in Advanced Liver Cancer
July 1, 2020
Novocure to Report Second Quarter 2020 Financial Results
June 2, 2020
Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data
May 13, 2020
China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
April 30, 2020
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
April 27, 2020
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I
April 3, 2020
Novocure Provides Business Update Related to COVID-19
March 20, 2020
German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany
March 19, 2020
Novocure Announces Optune Lua™ as the Brand Name for the NovoTTF-100L™ System
March 12, 2020
Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy
February 27, 2020
Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
January 21, 2020
Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
January 13, 2020
Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update
January 9, 2020
Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer